Multicancer blood tests have for years been hyped as a potential breakthrough in early cancer detection. But with news that one of the big names in the field, the Galleri test, failed to meet its ...

Please provide your email address to receive an email when new articles are posted on . Physicians who are not rheumatologists are less likely to test serum urate levels. Researchers said there are ...

A randomized clinical trial involving patients with gram-negative bacterial infection reports that rapid antimicrobial susceptibility testing directly from positive blood cultures is not superior to ...

The results are a blow to a fast-growing field that aims to catch cancer earlier, when treatment may be easier and more effective. HealthDay News — A blood test designed to find cancer early did not ...

Blood-based circulating tumor DNA (ctDNA) testing has proven to be insufficient for detecting KRAS mutations in patients with low-grade serous ovarian cancer (LGSOC), according to a study. The ...

CHICAGO -- Adding a multicancer early detection (MCED) blood test to standard of care did not reduce the number of cancers detected at stage III or IV across a dozen tumor types for which no screening ...